Annual report
3747.TEDINET S100XB0Y
Period2024-10-01 → 2025-09-30
Filed2025-12-17
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 143
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.8bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥1.8bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥2.0bn | 2022-10-01 → 2023-09-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.1bn | 2021-10-01 → 2022-09-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.2bn | 2020-10-01 → 2021-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | −¥9m | 2024-10-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥80m | 2023-10-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | −¥213m | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥160m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2m | 2022-10-01 → 2023-09-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥63m | 2021-10-01 → 2022-09-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥22m | 2020-10-01 → 2021-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥149m | 2024-10-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥83m | 2023-10-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥145m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥98m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥37m | 2022-10-01 → 2023-09-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥174m | 2021-10-01 → 2022-09-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥202m | 2020-10-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥157m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | −¥98m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥1.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2023-09-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.6bn | at 2022-09-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.5bn | at 2021-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥406m | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥413m | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥1.1bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.2bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2023-09-30v | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2022-09-30v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.1bn | at 2021-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥712m | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.0bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥712m | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥994m | at 2023-09-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥857m | at 2022-09-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥609m | at 2021-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥13m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥81m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥201m | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥270m | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥221m | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥253m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥124m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥134m | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥11m | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥29m | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥48m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥73m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥70m | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥10m | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥111m | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-20.2 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-13.63 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.1 | 2022-10-01 → 2023-09-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.15 | 2021-10-01 → 2022-09-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.05 | 2020-10-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥149.76 | at 2025-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥169.96 | at 2024-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥183.59 | at 2023-09-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥178.49 | at 2022-09-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥154.34 | at 2021-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 72.6% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.5% | at 2023-09-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.7% | at 2022-09-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.4% | at 2021-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | -12.6% | 2024-10-01 → 2025-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -7.7% | 2023-10-01 → 2024-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.8% | 2022-10-01 → 2023-09-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 14.5% | 2021-10-01 → 2022-09-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 20.0% | 2020-10-01 → 2021-09-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 91 | at 2025-09-30 | Cons. | Number of employees |
| Employees | 94 | at 2024-09-30 | Cons. | Number of employees |
| Employees | 93 | at 2023-09-30v | Cons. | Number of employees |
| Employees | 87 | at 2022-09-30v | Cons. | Number of employees |
| Employees | 90 | at 2021-09-30d | Cons. | Number of employees |
| Revenue | ¥1.8bn | 2024-10-01 → 2025-09-30 | Standalone | Net sales |
| Revenue | ¥1.8bn | 2023-10-01 → 2024-09-30 | Standalone | Net sales |
| Revenue | ¥1.9bn | 2022-10-01 → 2023-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2021-10-01 → 2022-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.1bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥60m | 2024-10-01 → 2025-09-30 | Standalone | Operating income |
| Operating income | ¥95m | 2023-10-01 → 2024-09-30 | Standalone | Operating income |
| Ordinary income | ¥59m | 2024-10-01 → 2025-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥94m | 2023-10-01 → 2024-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥194m | 2022-10-01 → 2023-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥221m | 2021-10-01 → 2022-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥230m | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥32m | 2024-10-01 → 2025-09-30 | Standalone | Income before income taxes |
| Profit before tax | −¥89m | 2023-10-01 → 2024-09-30 | Standalone | Income before income taxes |
| Net income | ¥28m | 2024-10-01 → 2025-09-30 | Standalone | Profit loss |
| Net income | −¥101m | 2023-10-01 → 2024-09-30 | Standalone | Profit loss |
| Net income | ¥161m | 2022-10-01 → 2023-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥201m | 2021-10-01 → 2022-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥190m | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.5bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥1.5bn | at 2024-09-30 | Standalone | Assets |
| Total assets | ¥1.7bn | at 2023-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.4bn | at 2022-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.3bn | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥303m | at 2025-09-30 | Standalone | Liabilities |
| Total liabilities | ¥311m | at 2024-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥1.2bn | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥1.2bn | at 2024-09-30 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2023-09-30v | Standalone | Net assets |
| Net assets / equity | ¥1.1bn | at 2022-09-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥947m | at 2021-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥653m | at 2025-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥890m | at 2024-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥3.89 | 2024-10-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.1 | 2023-10-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.47 | 2022-10-01 → 2023-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.94 | 2021-10-01 → 2022-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.5 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥172.03 | at 2025-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥168.14 | at 2024-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥182.24 | at 2023-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥159.77 | at 2022-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥131.83 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 80.3% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.5% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.5% | at 2023-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.2% | at 2022-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.2% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 2.3% | 2024-10-01 → 2025-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -8.0% | 2023-10-01 → 2024-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.1% | 2022-10-01 → 2023-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 19.2% | 2021-10-01 → 2022-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.4% | 2020-10-01 → 2021-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 7,444,800 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,444,800 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,444,800 | at 2023-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,444,800 | at 2022-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,444,800 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 85 | at 2025-09-30 | Standalone | Number of employees |
| Employees | 88 | at 2024-09-30 | Standalone | Number of employees |
| Employees | 87 | at 2023-09-30v | Standalone | Number of employees |
| Employees | 80 | at 2022-09-30v | Standalone | Number of employees |
| Employees | 83 | at 2021-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 60
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-09-30 | −¥12,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-09-30 | −¥12,000 |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-09-30 | −¥321m |
| Business Solutionreportable segment | capex | 2024-10-01 → 2025-09-30 | ¥889,000 |
| Business Solutionreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥473,000 |
| Business Solutionreportable segment | employees | at 2025-09-30 | 15 pure |
| Business Solutionreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥258m |
| Business Solutionreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥258m |
| Business Solutionreportable segment | segment assets | at 2025-09-30 | ¥29m |
| Business Solutionreportable segment | segment profit | 2024-10-01 → 2025-09-30 | −¥31m |
| Financial Solution Service Divisionreportable segment | capex | 2024-10-01 → 2025-09-30 | ¥2m |
| Financial Solution Service Divisionreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥17m |
| Financial Solution Service Divisionreportable segment | employees | at 2025-09-30 | 56 pure |
| Financial Solution Service Divisionreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥1.5bn |
| Financial Solution Service Divisionreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥1.5bn |
| Financial Solution Service Divisionreportable segment | segment assets | at 2025-09-30 | ¥1.4bn |
| Financial Solution Service Divisionreportable segment | segment profit | 2024-10-01 → 2025-09-30 | ¥394m |
| Health Care Business Divisionreportable segment | employees | at 2025-09-30 | 5 pure |
| Health Care Business Divisionreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥105m |
| Health Care Business Divisionreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥105m |
| Health Care Business Divisionreportable segment | revenue intersegment | 2024-10-01 → 2025-09-30 | ¥12,000 |
| Health Care Business Divisionreportable segment | segment assets | at 2025-09-30 | ¥91m |
| Health Care Business Divisionreportable segment | segment profit | 2024-10-01 → 2025-09-30 | −¥51m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-10-01 → 2025-09-30 | ¥3m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-10-01 → 2025-09-30 | ¥18m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-09-30 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-09-30 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-10-01 → 2025-09-30 | ¥12,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-09-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-09-30 | ¥312m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-09-30 | −¥36,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-09-30 | −¥36,000 |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-09-30 | −¥306m |
| Business Solutionreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥190,000 |
| Business Solutionreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥145,000 |
| Business Solutionreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥299m |
| Business Solutionreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥299m |
| Business Solutionreportable segment | segment assets | at 2024-09-30 | ¥74m |
| Business Solutionreportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥20m |
| Financial Solution Service Divisionreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥31m |
| Financial Solution Service Divisionreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥18m |
| Financial Solution Service Divisionreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥1.4bn |
| Financial Solution Service Divisionreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥1.4bn |
| Financial Solution Service Divisionreportable segment | segment assets | at 2024-09-30 | ¥1.4bn |
| Financial Solution Service Divisionreportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥417m |
| Health Care Business Divisionreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥105m |
| Health Care Business Divisionreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥105m |
| Health Care Business Divisionreportable segment | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥36,000 |
| Health Care Business Divisionreportable segment | segment assets | at 2024-09-30 | ¥134m |
| Health Care Business Divisionreportable segment | segment profit | 2023-10-01 → 2024-09-30 | −¥52m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-10-01 → 2024-09-30 | ¥31m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-10-01 → 2024-09-30 | ¥19m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-09-30 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-09-30 | ¥1.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥36,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-09-30 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-09-30 | ¥386m |
| Business Solutionreportable segment | employees | at 2025-09-30 | 10 pure |
| Financial Solution Service Divisionreportable segment | employees | at 2025-09-30 | 56 pure |
| Health Care Business Divisionreportable segment | employees | at 2025-09-30 | 4 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,298
| Item | Context | Value | Unit |
|---|---|---|---|
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row8Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row9Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row10Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row11Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row12Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Remuneration etc paid by group to each director or other officer (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)なお、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding amounts of notes and accounts receivable trade and contract assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding accumulated depreciation of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text) | CurrentYearInstant | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration | Text · Plus | |
| Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding write downs of inventories (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on disposal of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Description of significant transactions not requiring use of cash or cash equivalents (text) | CurrentYearDuration | Text · Plus | |
| Notes leases consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities consolidated financial statements (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |